Pathophysiological Aspects of Alcohol Metabolism in the Liver

Pathophysiological Aspects of Alcohol Metabolism in the Liver

Alcoholic liver disease (ALD) is a globally prevalent chronic liver disease caused by chronic or binge consumption of alcohol. The liver is the major organ that metabolizes alcohol; therefore, it is particularly sensitive to alcohol intake. Metabolites and byproducts generated during alcohol metabol...

Full description

Bibliographic Details
Main Authors:	Jeongeun Hyun, Jinsol Han, Chanbin Lee, Myunghee Yoon, Youngmi Jung
Format:	Article
Language:	English
Published:	MDPI AG 2021-05-01
Series:	International Journal of Molecular Sciences
Subjects:	alcoholic liver disease alcohol metabolism lipotoxicity inflammation fibrosis
Online Access:	https://www.mdpi.com/1422-0067/22/11/5717

Similar Items

Serum metabolites in non-alcoholic fatty-liver disease development or reversion; a targeted metabolomic approach within the PREDIMED trial
by: Christopher Papandreou, et al.
Published: (2017-09-01)

Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation
by: William Peverill, et al.
Published: (2014-05-01)

Role of Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Implications for Prevention and Therapy
by: Johanna C. Arroyave-Ospina, et al.
Published: (2021-01-01)

Molecular Basis and Current Treatment for Alcoholic Liver Disease
by: Juan Armendariz-Borunda, et al.
Published: (2010-04-01)

Transcriptional Regulation in Non-Alcoholic Fatty Liver Disease
by: Sandra Steensels, et al.
Published: (2020-07-01)

Can Walnut Serve as a Magic Bullet for the Management of Non-Alcoholic Fatty Liver Disease?
by: Mi-Young Kim, et al.
Published: (2021-12-01)

Non-Alcocholic Fatty Liver Disease: Modern View on Pathogenesis, Diagnosis and Treatment
by: V.B. Yagmur
Published: (2013-09-01)

Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients
by: Francesca Cainelli, et al.
Published: (2020-02-01)

The Progression of Liver Fibrosis in Non-alcoholic Fatty Liver Disease
by: Moon Young Kim
Published: (2017-06-01)

Features of cellular immunity and regeneration for alcoholic fibrosis of the liver
by: N. D. Gazatova, et al.
Published: (2019-05-01)

Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
by: Kalliopi Pafili, et al.
Published: (2021-08-01)

Computational Hypothesis: How Intra-Hepatic Functional Heterogeneity May Influence the Cascading Progression of Free Fatty Acid-Induced Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Hermann-Georg Holzhütter, et al.
Published: (2021-03-01)

Alcohol Abstinence Rescues Hepatic Steatosis and Liver Injury via Improving Metabolic Reprogramming in Chronic Alcohol-Fed Mice
by: Aiwen Pi, et al.
Published: (2021-09-01)

Alcoholic Liver Disease: Alcohol Metabolism, Cascade of Molecular Mechanisms, Cellular Targets, and Clinical Aspects
by: Rolf Teschke
Published: (2018-11-01)

Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trial
by: Bjørn Stæhr Madsen, et al.
Published: (2018-02-01)

New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis
by: Nahum Mendez-Sanchez, et al.
Published: (2018-07-01)

Beyond the Paradigm of Weight Loss in Non-Alcoholic Fatty Liver Disease: From Pathophysiology to Novel Dietary Approaches
by: Angelo Armandi, et al.
Published: (2021-06-01)

Association between sonographic diagnosis of fatty liver with histopathologic abnormalities and liver biopsy findings in middle age patient with non-alcoholic fatty liver disease
by: Hamid Kalantari, et al.
Published: (2016-01-01)

Nonalcoholic fatty liver disease and alcohol-related liver disease: From clinical aspects to pathophysiological insights
by: Kenichi Ikejima, et al.
Published: (2020-10-01)

Association of Cardiovascular Risk Factors and Metabolic Syndrome with non-alcoholic and alcoholic fatty liver disease: a retrospective analysis
by: A. L. Han
Published: (2021-05-01)

Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver Transplant
by: Stefano Gitto, et al.
Published: (2016-04-01)

Current concepts in alcohol metabolism
by: Juan Caballería, MD
Published: (2003-04-01)

Contemporary aspects of the diagnostics of alcoholic liver disease
by: Nikolić Jelenka, et al.
Published: (2012-01-01)

Perspectives on Mitochondria–ER and Mitochondria–Lipid Droplet Contact in Hepatocytes and Hepatic Lipid Metabolism
by: Xiaowen Ma, et al.
Published: (2021-09-01)

Markers of Monocyte Activation, Inflammation, and Microbial Translocation Are Associated with Liver Fibrosis in Alcohol Use Disorder
by: Daniel Fuster, et al.
Published: (2021-08-01)

Puerariae Lobatae radix flavonoids and puerarin alleviate alcoholic liver injury in zebrafish by regulating alcohol and lipid metabolism
by: Yu-Shi Liu, et al.
Published: (2021-02-01)

Combined herbal medicine for chronic alcoholic liver disease
by: V. V. Skvortsov, et al.
Published: (2020-10-01)

The History of Alcoholic Liver Disease: From an Unrecognized Disease to One of the Most Frequent Diseases in Hepatology
by: Helmut K. Seitz, et al.
Published: (2021-02-01)

The association of leptin with severity of non-alcoholic fatty liver disease: A population-based study
by: Laura Rotundo, et al.
Published: (2018-12-01)

CHANGES IN FIBROSIS UNDER THE INFLUENCE OF TREATMENT OF PATIENTS WITH ALCOHOLIC CIRRHOSIS OF THE LIVER IN COMBINATION WITH OBESITY USING ADEMETHYANINIUM AND ARGININE GLUTAMATE
by: N.R. Matkovska
Published: (2020-11-01)

Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain
by: Julia De Ternay, et al.
Published: (2019-05-01)

Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
by: Chanbin Lee, et al.
Published: (2019-10-01)

Molecular factors associated with regression of liver fibrosis of alcoholic etiology
by: Ya. V. Kiseleva, et al.
Published: (2021-02-01)

Non‐alcoholic fatty liver disease and heart failure with preserved ejection fraction: from pathophysiology to practical issues
by: Romain Itier, et al.
Published: (2021-04-01)

Clinical and prognostic value of metabolic disorders in non-alcoholic fatty liver disease
by: Ya. M. Vakhrushev, et al.
Published: (2020-12-01)

The role of increased gastrointestinal alcohol production in patients with the metabolic syndrome: Implications for the pathogenesis of non-alcoholic fatty liver disease
by: Menezes, Colin Nigel
Published: (2007)

Sex hormones abnormalities in non-alcoholic fatty liver disease: pathophysiological and clinical implications
by: Angelo Di Vincenzo, et al.
Published: (2021-08-01)

Epidemiology of Alcoholic Liver Disease in Korea
by: Sung Won Lee
Published: (2020-08-01)

Therapeutic and Protective Effects of Liposomal Encapsulation of Astaxanthin in Mice with Alcoholic Liver Fibrosis
by: Yu Chiuan Wu, et al.
Published: (2019-08-01)

The Enhanced Liver Fibrosis test is associated with liver-related outcomes in postmenopausal women with risk factors for liver disease
by: Paul M. Trembling, et al.
Published: (2020-04-01)